TAO Synergies, a crypto vault company focused on the Bittensor ecosystem, announced it has signed a securities purchase agreement to raise $11 million in a private placement. The agreement involves the issuance of 11,000 new Series E convertible preferred shares, par value $1,000 per share, convertible into the company's common stock at $8 per share. Participation in this round includes existing investor and digital asset strategy advisor James Altucher, as well as new investor DCG, and is expected to close around October 15, 2025. Altucher stated that this financing will further support TAO Synergies' continued growth in TAO token holdings and expand revenue opportunities within the Bittensor ecosystem. TAO Synergies, formerly the biotech company Synaptogenix, rebranded in June of this year and transitioned to a Bittensor-centric strategy. It is currently the largest public holder of TAO tokens in the ecosystem, holding 42,111 TAO tokens, valued at over $18.2 million. (The Block)